loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 50582 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 DOXYCYCLINE HYCLATE (2)

filter

01 MAYNE PHARMA (2)

filter

01 CAPSULE, DELAYED RELEASE;ORAL (2)

filter

01 EQ 100MG BASE (1)

02 EQ 75MG BASE (1)

filter

01 USA (2)

URL Supplier Web Content
CAPSULE, DELAYED RELEA...
EQ 75MG BASE
DORYX
USA
50582
2001-08-13
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CAPSULE, DELAYED RELEA...
EQ 100MG BASE
DORYX
USA
50582
1985-07-22
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 50582

Looking for CTD TGA MCC DOSSIER APPLICATION 50582 2

19

Mayne Pharma, based in Australia, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 50582 and regulatory information .

proudly manufactured in the

approval since 2001-08-13

Mayne Pharma's DORYX CAPSULE, DELAYED RELEASE;ORAL, medication with EQ 75MG BASE of DOXYCYCLINE HYCLATE.

18

Mayne Pharma, based in Australia, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is DOXYCYCLINE HYCLATE, with a corresponding application number 50582 and regulatory information .

proudly manufactured in the

approval since 1985-07-22

Mayne Pharma's DORYX CAPSULE, DELAYED RELEASE;ORAL, medication with EQ 100MG BASE of DOXYCYCLINE HYCLATE.

Post Enquiry
POST ENQUIRY